Unichem Laboratories Limited (UNICHEMLAB.BO)

INR 743.95

(-2.17%)

Operating Income Summary of Unichem Laboratories Limited

  • Unichem Laboratories Limited's latest annual operating income in 2023 was - INR , up 19.82% from previous year.
  • Unichem Laboratories Limited's latest quarterly operating income in 2024 Q1 was 151.71 Million INR , up 226.86% from previous quarter.
  • Unichem Laboratories Limited reported an annual operating income of -1.72 Billion INR in 2022, down -609.78% from previous year.
  • Unichem Laboratories Limited reported an annual operating income of -243.56 Million INR in 2021, down -23.58% from previous year.
  • Unichem Laboratories Limited reported a quarterly operating income of -1.27 Billion INR for 2023 Q4, down -1342.34% from previous quarter.
  • Unichem Laboratories Limited reported a quarterly operating income of -1.38 Billion INR for 2023 FY, up 19.82% from previous quarter.

Annual Operating Income Chart of Unichem Laboratories Limited (2023 - 2005)

Historical Annual Operating Income of Unichem Laboratories Limited (2023 - 2005)

Year Operating Income Operating Income Growth
2023 - INR 19.82%
2022 -1.72 Billion INR -609.78%
2021 -243.56 Million INR -23.58%
2020 -197.08 Million INR 88.1%
2019 -1.65 Billion INR 5.55%
2018 -1.75 Billion INR 16.45%
2017 -2.09 Billion INR -106.18%
2016 -1.01 Billion INR -179.72%
2015 1.27 Billion INR 60.15%
2014 797.18 Million INR -48.49%
2013 1.54 Billion INR 16.08%
2012 1.33 Billion INR 42.02%
2011 938.64 Million INR -27.31%
2010 1.29 Billion INR -16.3%
2009 1.54 Billion INR 19.36%
2008 1.29 Billion INR 72.53%
2007 749.13 Million INR -16.12%
2006 893.13 Million INR 11.57%
2005 800.49 Million INR 0.0%

Peer Operating Income Comparison of Unichem Laboratories Limited

Name Operating Income Operating Income Difference
Ajanta Pharma Limited 19.67 Billion INR 100.0%
Amrutanjan Health Care Limited 457.54 Million INR 100.0%
Sigachi Industries Limited 1.47 Billion INR 100.0%
Bal Pharma Limited 233.9 Million INR 100.0%
Ind-Swift Laboratories Limited 4.42 Billion INR 100.0%
Medico Remedies Limited 100.3 Million INR 100.0%
Lasa Supergenerics Limited -458 Million INR 100.0%
Venus Remedies Limited 534.65 Million INR 100.0%
Sun Pharma Advanced Research Company Limited -4.11 Billion INR 100.0%
Alpa Laboratories Limited 184.49 Million INR 100.0%
Nectar Lifesciences Limited 923.8 Million INR 100.0%
Shilpa Medicare Limited 1.36 Billion INR 100.0%
Aarti Drugs Limited 7.14 Billion INR 100.0%
Lupin Limited 28.04 Billion INR 100.0%
Aurobindo Pharma Limited 42.2 Billion INR 100.0%
Zydus Lifesciences Limited 43.1 Billion INR 100.0%
Windlas Biotech Limited 1.29 Billion INR 100.0%
Suven Life Sciences Limited -1.22 Billion INR 100.0%
Eris Lifesciences Limited 5.18 Billion INR 100.0%
Valiant Laboratories Limited - INR NaN%
J. B. Chemicals & Pharmaceuticals Limited 14.28 Billion INR 100.0%
Solara Active Pharma Sciences Limited -3.85 Billion INR 100.0%
Ipca Laboratories Limited 7.98 Billion INR 100.0%
Bliss GVS Pharma Limited 1.23 Billion INR 100.0%
Achyut Healthcare Limited 4.43 Million INR 100.0%
Sun Pharmaceutical Industries Limited 104.3 Billion INR 100.0%
Bajaj HealthCare Limited - INR NaN%
RPG Life Sciences Limited 2.29 Billion INR 100.0%
Mankind Pharma Limited 21.51 Billion INR 100.0%
Laurus Labs Limited 3.94 Billion INR 100.0%
Piramal Pharma Limited 4.55 Billion INR 100.0%
Syncom Formulations (India) Limited 249.25 Million INR 100.0%
Torrent Pharmaceuticals Limited 25.33 Billion INR 100.0%
Alembic Pharmaceuticals Limited 5.75 Billion INR 100.0%
Glenmark Pharmaceuticals Limited 6.5 Billion INR 100.0%
Sequent Scientific Limited - INR NaN%
Novartis India Limited 626.5 Million INR 100.0%
Wanbury Limited 569.71 Million INR 100.0%
Suven Pharmaceuticals Limited 4.6 Billion INR 100.0%
Wockhardt Limited -670 Million INR 100.0%
Themis Medicare Limited 392.58 Million INR 100.0%
Jagsonpal Pharmaceuticals Limited 508.13 Million INR 100.0%
Jubilant Pharmova Limited 5.18 Billion INR 100.0%
Glenmark Life Sciences Limited 8.97 Billion INR 100.0%
Dr. Reddy's Laboratories Limited 67.72 Billion INR 100.0%
Divi's Laboratories Limited 33.08 Billion INR 100.0%
NATCO Pharma Limited 25.96 Billion INR 100.0%
Gufic Biosciences Limited 1.32 Billion INR 100.0%
IOL Chemicals and Pharmaceuticals Limited 1.59 Billion INR 100.0%
Ind-Swift Limited 1.22 Billion INR 100.0%
Procter & Gamble Health Limited 2.78 Billion INR 100.0%
FDC Limited 2.98 Billion INR 100.0%
Krebs Biochemicals & Industries Limited -151.95 Million INR 100.0%
Granules India Limited 6.81 Billion INR 100.0%
Medicamen Biotech Limited - INR NaN%
Alkem Laboratories Limited 19.46 Billion INR 100.0%
AstraZeneca Pharma India Limited 1.71 Billion INR 100.0%
Biofil Chemicals and Pharmaceuticals Limited 9.06 Million INR 100.0%
Brooks Laboratories Limited 14.44 Million INR 100.0%
Megasoft Limited -121.1 Million INR 100.0%
ZIM Laboratories Limited 253.82 Million INR 100.0%
Strides Pharma Science Limited 5.22 Billion INR 100.0%
Neuland Laboratories Limited 5.31 Billion INR 100.0%
Morepen Laboratories Limited 4.17 Billion INR 100.0%
Hikal Limited 32.11 Million INR 100.0%
Indoco Remedies Limited 1.29 Billion INR 100.0%
Aarti Pharmalabs Limited 3.12 Billion INR 100.0%
Kilitch Drugs (India) Limited 208.05 Million INR 100.0%
Mangalam Drugs & Organics Limited 27.45 Million INR 100.0%
Hester Biosciences Limited 364.81 Million INR 100.0%